Literature DB >> 19100508

Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles.

Motonao Nakao1, Shigeto Kawauchi, Tomoko Furuya, Tetuji Uchiyama, Jun Adachi, Takae Okada, Kenzo Ikemoto, Atsunori Oga, Kohsuke Sasaki.   

Abstract

It is important to estimate the biological characteristics of tumors, including the nodal status at the time of diagnosis for optimal treatment of individual cancer patients. Array-based comparative genomic hybridization (aCGH) was performed on 77 sporadic colorectal adenocarcinomas using a chip spotted with 4030 BAC clones. The nodal status was compared with an aCGH profiles depicted using a combination of decision-tree classifier and a Self-Organizing Map (SOM) analysis. Node metastasis was not detected in any of the 6 poorly differentiated adenocarcinomas with a 3q loss. A SOM analysis following the decision-tree classification of the aCGH data allowed for the differentiation in chromosomal regions between high- and low-level decreases in the DNA copy number. Node metastasis was detected in all 5 tumors with the high-level decrease in DNA copy number at Xp, irrespective of the histological type. Node metastasis was also found exclusively in 6 tumors with increase in DNA copy number at the chromosomal region between 11q13.3 and 11q22.3. Copy number aberrations linked to nodal metastasis were identified more collectively by the combination of the decision-tree classifier and a SOM analysis than by the conventional analysis method in aCGH analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19100508     DOI: 10.1016/j.cancergencyto.2008.09.013

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  20 in total

1.  DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.

Authors:  Elisabetta Bigagli; Carlotta De Filippo; Cinzia Castagnini; Simona Toti; Francesco Acquadro; Francesco Giudici; Marilena Fazi; Piero Dolara; Luca Messerini; Francesco Tonelli; Cristina Luceri
Journal:  Cell Oncol (Dordr)       Date:  2016-10-05       Impact factor: 6.730

2.  TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection.

Authors:  Apostolos Klinakis; Theodoros Rampias
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

3.  Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.

Authors:  Tsuyoshi Yoshida; Takumi Kobayashi; Masaya Itoda; Taika Muto; Ken Miyaguchi; Kaoru Mogushi; Satoshi Shoji; Kazuro Shimokawa; Satoru Iida; Hiroyuki Uetake; Toshiaki Ishikawa; Kenichi Sugihara; Hiroshi Mizushima; Hiroshi Tanaka
Journal:  Cancer Inform       Date:  2010-07-29

4.  Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to explore.

Authors:  José Perea; Juana M Cano; Daniel Rueda; Juan L García; Lucía Inglada; Irene Osorio; María Arriba; Jessica Pérez; Miriam Gaspar; Tamara Fernández-Miguel; Yolanda Rodríguez; Javier Benítez; Rogelio González-Sarmiento; Miguel Urioste
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

Review 5.  Integration of genome scale data for identifying new players in colorectal cancer.

Authors:  Viktorija Sokolova; Elisabetta Crippa; Manuela Gariboldi
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

6.  Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.

Authors:  Sjoerd C Bruin; Christiaan Klijn; Gerrit-Jan Liefers; Linde M Braaf; Simon A Joosse; Eric H van Beers; Victor J Verwaal; Hans Morreau; Lodewyk F Wessels; Marie-Louise F van Velthuysen; Rob A E M Tollenaar; Laura J Van't Veer
Journal:  BMC Cancer       Date:  2010-12-02       Impact factor: 4.430

7.  A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment.

Authors:  Farzana Jasmine; Ronald Rahaman; Charlotte Dodsworth; Shantanu Roy; Rupash Paul; Maruf Raza; Rachelle Paul-Brutus; Mohammed Kamal; Habibul Ahsan; Muhammad G Kibriya
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

8.  Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues.

Authors:  Katumi Tsuji; Shigeto Kawauchi; Soichiro Saito; Tomoko Furuya; Kenzo Ikemoto; Motonao Nakao; Shigeru Yamamoto; Masaaki Oka; Takashi Hirano; Kohsuke Sasaki
Journal:  BMC Cancer       Date:  2010-01-14       Impact factor: 4.430

9.  Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer.

Authors:  Leanne Stevenson; Wendy L Allen; Richard Turkington; Puthen V Jithesh; Irina Proutski; Gail Stewart; Heinz-Josef Lenz; Sandra Van Schaeybroeck; Daniel B Longley; Patrick G Johnston
Journal:  Clin Cancer Res       Date:  2012-08-02       Impact factor: 12.531

10.  A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.

Authors:  Tao Xie; Giovanni D' Ario; John R Lamb; Eric Martin; Kai Wang; Sabine Tejpar; Mauro Delorenzi; Fred T Bosman; Arnaud D Roth; Pu Yan; Stephanie Bougel; Antonio Fabio Di Narzo; Vlad Popovici; Eva Budinská; Mao Mao; Scott L Weinrich; Paul A Rejto; J Graeme Hodgson
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.